Context Therapeutics Inc. (CNTX)
NASDAQ·Healthcare·Biotechnology
$2.46
+5.13%
Mkt Cap $215.00M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (3 analysts)
$5.25
Range $4.50 – $6.00
Implied Upside
+113.4%
Consensus $5.25 vs current $2.46
NASDAQ·Healthcare·Biotechnology
$2.46
+5.13%
Mkt Cap $215.00M
Buy
5
Hold
0
Sell
0
Price Target (3 analysts)
$5.25
Range $4.50 – $6.00
+113.4%
Consensus $5.25 vs current $2.46